Tumour environment found to trigger cells to metastasize
The environment surrounding a tumour can trigger metastatic behaviour in cancer cells...
List view / Grid view
News
Alzheimer’s Tau protein forms toxic complexes with cell membranes
Researchers identify the sequence and structural factors that drive Tau interaction with membranes...
GDF11 protein found to inactivate triple-negative breast cancer cells
Researchers detail a possible way to re-engage a tumour suppressor protein, that has been found to be inactivated in triple-negative breast cancer cells...
AFM-CRISPR technique used to map DNA mutations
Nanomapping technology may transform the way disease-causing genetic mutations are diagnosed and discovered...
EMA to relocate to Amsterdam, the Netherlands
The EMA will relocate to Amsterdam in the Netherlands. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest...
Pre-diabetes discovery marks step towards precision medicine
Researchers have identified three specific molecules that accurately indicate insulin resistance - a major predictor of diabetes...
Reducing TIA1 improves nerve cell health in Alzheimer’s disease
Researchers have described a unique model for the biology of Alzheimer's disease which may lead to an entirely novel approach for treating the disease...
An interview with Bjorg K. Hunter, Device Engineering Manager from GSK ahead of Pre-Filled Syringes Europe 2018
A debate on the impact of PFS regulation at Pre-Filled Syringes 2018...
Hindering cadherin-22 may reduce the spread of cancer
Scientists have made a discovery that could reduce the spread of cancer by hindering a protein that binds cancer cells together and allows them to invade tissues...
CXCL5 protein may protect against coronary artery disease
Researchers have identified a possible genetic basis for coronary artery disease...
Therapeutic target discovered for ER+ breast cancer
Researchers have identified a protein that can be targeted to suppress the growth of a common type of breast cancer...
Could Milan be the new home for the EMA?
Wayne Pines, President of Healthcare at APCO Worldwide in Washington DC and a former Associate Commissioner of the FDA believes Milan is a logical choice for the relocation of the EMA...
Mn-PyC3A MRI contrast agent may be a safer alternative to gadolinium
Researchers have developed a potential alternative to gadolinium-based contrast agents for magnetic resonance imaging...
Scientists reverse diabetes using modified blood stem cells
Researchers have successfully reversed type 1 diabetes by infusing blood stem cells pre-treated to produce more PD-L1...
Molecular pathway offers treatment targets for pulmonary fibrosis
A study has identified a molecular pathway that appears to be critical to the development of fibrosis...